v3.26.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
OPERATING EXPENSES    
Research and development expenses $ 281,014 $ 138,324
General and administrative expenses 1,475,082 1,366,778
Total operating expenses 1,756,096 1,505,102
LOSS FROM OPERATIONS (1,756,096) (1,505,102)
LOSS, BEFORE INCOME TAX (1,756,096) (1,505,102)
Income tax benefit (expense)
NET LOSS $ (1,756,096) $ (1,505,102)
Net loss per share attributable to common shareholders, basic $ (0.12) $ (0.13)
Net loss per share attributable to common shareholders, diluted $ (0.12) $ (0.13)
Weighted average common shares outstanding used in computing net loss per share attributable to common shareholders, basic 15,233,501 11,435,362
Weighted average common shares outstanding used in computing net loss per share attributable to common shareholders, diluted 15,233,501 11,435,362